Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 10, Issue 5 II SUPPL., 1997, Pages

  Gyurko, Robert ^a,b   Tran, Dan ^a   Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Cardiovascular Research Center   (United States)

Author keywords

angiotensin; Antisense oligodeoxynucleotide; AT1 receptor binding; AT2 receptors; fluorescent labelling; heart rate; hypertension; hypothalamus; uptake

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA;

ANIMAL MODEL; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; HEART RATE; HYPERTENSION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030998270     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)00076-9     Document Type: Conference Paper

References (35)

1. Phillips MI. Function of brain angiotensin. Ann Rev Physiol. 49:1987;413-435.
2. Bunnemann B, Fuxe K, Ganten D. The renin-angiotensin system in the brain: an update 1993. Regul Pept. 46:1993;487-509.
3. Hermann K, Raizada MK, Sumners C, Phillips MI. Immunocytochemical and biochemical characterization of angiotensin I and II in cultured neuronal and glial cells from rat brain. Neuroendocrinology. 47:1988;125-132.
4. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin-angiotensin system. Regul Pept. 43:1992;1-20.
5. Dostal DE, Rothblum KN, Baker KM. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: determination of renin and angiotensinogen mRNA levels in various tissues. Anal Biochem. 233:1994;239-250.
6. Berecek KH, Kirk KA, Nagahama S, Oparil S. Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol. 252:1987;H796-H806.
7. Phillips MI, Mann JFE, Haebara H, et al. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature. 270:1977;445-447.
8. Phillips MI, Kimura B. Brain angiotensin in the developing spontaneously hypertensive rat. J Hypertens. 6:1988;607-612.
9. Stamler JF, Brody MJ, Phillips MI. The central and peripheral effects of captopril (SQ14225) on the arterial pressure of the spontaneously hypertensive rat. Brain Res. 186:1980;499-503.
10. 1 receptor mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 49:1993;167-174.
11. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension. 25:1995;314-319.
12. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension. 29:((2)):1997;177-187.
13. Neckers L, Whitesell L, Rosolen A, Geselowitz DA. Antisense inhibition of oncogene expression. Crit Rev Oncogene. 3:1992;175-231.
14. Murphy TJ, Alexander RW, Griendling KK, et al. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 35:1991;233-236.
15. Burgess T, Farrell C. The antiproliferative activity of c-myb and a c-myb antisense oligonucleotides in smooth muscle cells is caused by a non-antisense mechanism. Proc Natl Acad Sci USA. 92:1995;4051-4055.
16. 1a receptor. Reg Pept. 59:1995;171-182.
17. Loke SL, Stein CA, Zhang XH, et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA. 86:1989;3474-3478.
18. Li B, Hughes JA, Phillips MI: Uptake and efflux of intact antisense phosphorothioate deoxynucleotide directed against angiotensin receptors in bovine adrenal cells. Neurochem Intl (in press).
19. 1 receptor mRNA antisense oligonucleotide inhibits central angiotensin induced thirst and vasopressin. Regul Pept. 54:1994;543-551.
20. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
21. Caufield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330,23:1994;1629-1633.
22. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Eng J Med. 330,23:1994;1634-1638.
23. Jacoby HJ, Lindpainter K, Lincoln SE, et al. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 67:1991;213-224.
24. Kimura S, Mullins JJ, Bunnemann B, et al. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBRO J. 11,3:1992;821-827.
25. Vinson GP, Ho MM, Puddefoot JR. The distribution of angiotensin II type-1 receptor and the tissue renin-angiotensin systems. Mol Med Today. 1,1:1995;35-39.
26. Naruse M, Naruse K, McKenzie JC, et al. Regional distribution of renin and angiotensinogen in the brain of normotensive (WKY) and spontaneously hypertensive (SHR) rats. Brain Res. 333:1985;147-150.
27. Gehlert DR, Speth RC, Wamsley JK. Quantitative autoradiography of angiotensin II receptors in the SHR. Peptides. 1986;1021-1027.
28. Salaymeh B, Lee MF, Weyhenmeyer JA. A comparison of CNS angiotensin II binding in the hypothalamus-thalamus-septum-midbrain region of developing spontaneously hypertensive and normotensive rats. J Hypertens. 4:1986;617-622.
29. Raizada MK, Muther TF, Sumners C. Increased angiotensin II receptors in neuronal cultures from hypertensive rat brain. Am J Physiol. 247:1984;C364-C372.
30. Saavedra JM, Correa MA, Kurhiara M, Shigematsu K. Increased number of angiotensin receptors in the subfornical organ of spontaneously hypertensive rats. J Hypertens. 4,5:1986;S27-S30.
31. Kamitani A, Higashimori K, Kohara K, et al. The effects of central administration of angiotensin II type-1 receptor antagonist, CV-1174, in nephrectomized spontaneously hypertensive rats. Clin Exp Pharm Physiol. 21:1994;271-276.
32. DePasquale MJ, Fossa AA, Holt WF, Mangiapane ML. Dentral DuP 753 does not lower blood pressure in spontaneously hypertensive rats. Hypertension. 19:1992;668-671.
33. Unger T, Badoer E, Ganten D, et al. Brain angiotensin: pathways and pharmacology. Circulation. 77:1988;I40-I54.
34. Hogarty DC, Tran DN, Puig V, Phillips MI. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin. Brain Res. 637:1994;126-132.
35. Iversen PL, Mata J, Tracewello WG, Zon G. Pharmacokinetics of an antisense phosphorthioate oligodeoxynucleotide against rev from human immunodeficiency virus type-1 in the adult male rat following single injections and continuous infusion. Antis Res Dev. 4:1994;43-52.